Intercept Pharmaceuticals, Inc… (NASDAQ:ICPT)

30 Big Biotech Events Coming in 2018

Over the past year, biotech companies have more or less kept pace with the markets, but they have the potential to break out in 2018. While they have been the ...
Read Full Story »

Top 10 Biopharma Events Kicking Off 2018

Biotechnology and pharmaceutical companies generally face a fair-to-great amount of risk based on the lengthy vetting process for their drug candidates, should a study come back negative or should a ...
Read Full Story »

Jefferies Has 4 Red-Hot Biotech Stock Picks for December

Barring a huge meltdown, the S&P 500 will once again have a double-digit year of gains, and most investors should be looking at their 401(k)s and other accounts with some ...
Read Full Story »

Windstream, Intercept Pharma Dip into Wednesday’s 52-Week Low Club

September 27, 2017: Here are four stocks trading with heavy volume among 52 equities making new 52-week lows in Wednesday's session. On the NYSE, advancers led decliners by about 4 ...
Read Full Story »

Versartis, Intercept Pharma Plunge into Friday’s 52-Week Low Club

September 22, 2017: Here are four stocks trading with heavy volume among 35 equities making new 52-week lows in Friday's session. On the NYSE, advancers led decliners by nearly 2 ...
Read Full Story »

Kroger, Bed Bath & Beyond Dive into Thursday’s 52-Week Low Club

September 21, 2017: Here are four stocks trading with heavy volume among 40 equities making new 52-week lows in Thursday's session. On the NYSE, decliners led advancers by about 4 ...
Read Full Story »

FDA Crashes Down on Intercept’s Deadly Drug

Intercept Pharmaceuticals Inc. (NASDAQ: ICPT) shares tumbled on Thursday after it came to light that the U.S. Food and Drug Administration (FDA) had issued a warning about the firm’s liver ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Biogen, Electronic Arts, Gap, Intuit, J&J, 3M, Intercept, AutoZone and More

Stocks were looking for direction on Wednesday, but this after the major indexes have all hit fresh all-time highs. The one trend that has dominated this bull market is that ...
Read Full Story »

Hewlett Packard Enterprise, Discovery Dip into Tuesday’s 52-Week Low Club

September 12, 2017: Here are four stocks trading with heavy volume among 27 equities making new 52-week lows in Tuesday's session. On the NYSE, advancers led decliners by about 3 ...
Read Full Story »
FDA_logo

10 Major Pharma and FDA Catalysts Coming in December

Biotech and pharmaceutical companies are generally involved in the lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk to a ...
Read Full Story »
New York Stock Exchange

Top Analyst Upgrades and Downgrades: Apache, Baker Hughes, Intercept Pharmaceutical, Rite Aid, Synchrony Financial, US Steel and More

Well the volatility is back, at least for now, and Thursday's big loss is starting to remind investors how the first six weeks of the 2016 trading year went. The ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: Alibaba, Amazon, BofA, Cypress Semi, Flextronics, JC Penney, Lululemon, Microsoft and More

Stocks were indicated to have a strong open on Friday after Japan cut its interest rates into negative territory to follow Europe on easing trends and quantitative easing. This was ...
Read Full Story »
automatic inspection machine

Intercept Pharma Disappoints on FDA Extension

Intercept Pharmaceuticals Inc. (NASDAQ: ICPT) lagged the markets on Friday morning as the result of an extension by the U.S. Food and Drug Administration (FDA). The company announced that the ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Alibaba, Mobileye, NetApp, Nike, Salesforce.com, Stratasys and More

Stocks were marginally lower on Thursday, but investors need to keep in mind that stocks are just barely off all-time highs in the Dow and S&P. Investors keep proving over ...
Read Full Story »
biotech

Is This the End of the Growth Phase for Intercept?

Investors are not too happy with Intercept Pharmaceuticals Inc. (NASDAQ: ICPT) after it released the terms for its most recent clinical trial. Over the course of 2015, shares have nearly ...
Read Full Story »